NANOPARTICLE-BASED MEDICINES: ADVANTAGES AND SAFETY

Dinora K. B.


Annotatsiya

Nanoparticle-based drugs are recognized as a revolutionary approach in modern medicine. The article examines the advantages of nanoparticle technology in drug development, their safety and clinical application. Nanoparticles allow for targeted drug delivery, increased efficacy, and reduced side effects. At the same time, issues regarding their toxicity and long-term safety are also analyzed.


Adabiyotlar

  1. Barenholz, y. (2012). Doxil—the first fda-approved nano-drug: lessons learned. Journal of controlled release , 160(2), 117-134.
  2. Zhang, l., gu , f. X., chan, j. M., Wang, A. Z., langer, r. S., & farokhzad, o. C. (2016). Nanoparticles in medicine: therapeutic applications and developments. Clinical pharmacology & therapeutics , 83(5), 761-769.
  3. O berdörster, g., oberdörster, e., & oberdörster, j. (2005). Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environmental health perspectives , 113(7), 823-839.
  4. Nel, A., Xia, T., Mädler, L., & Li, N. (2006). Toxic potential of materials at the nanolevel. Science , 311(5761), 622-627.
  5. Desai N. Challenges in development of nanoparticle-based therapeutics // The AAPS journal. - 2012. - T. 14. – no. 2. - S. 282-295.
  6. Huang Y. et al. Nanotechnology's frontier in combating infectious and inflammatory diseases: prevention and treatment //Signal Transduction and Targeted Therapy. - 2024. - T. 9. – no. 1. – S. 34.
  7. Joseph TM et al. Nanoparticles: taking a unique position in medicine //Nanomaterials. - 2023. - T. 13. – no. 3. - S. 574.
  8. Liu Y. et al. Advances in nanotechnology for enhancing the solubility and bioavailability of poorly soluble drugs // Drug design, development and therapy. - 2024. - S. 1469 -1495.
  9. Alshawwa SZ et al. Nanocarrier drug delivery systems: characterization, limitations, future perspectives and implementation of artificial intelligence //Pharmaceutics. - 2022. - T. 14. – no. 4. – S. 883.
  10. Bezbaruah R. et al. Nanoparticle-based delivery systems for vaccines //Vaccines. - 2022. - T. 10. – no. 11. – S. 1946.
  11. Thapa RK, Kim JO Nanomedicine-based commercial formulations: Current developments and future prospects //Journal of Pharmaceutical Investigation. - 2023. - T. 53. – no. 1. – S. 19-33.
  12. Khalifa MMAH Safety of nanoparticles in medicine //Nanocarriers in neurodegenerative disorders. – CRC Press, 2024. – P. 94-10